Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Insider Filings - EVANS DARON
Last Updated 
9-Feb-10
Enter symbol:
symbol lookup
 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

EVANS DARON: Declared Holdings
Company/RelationshipReportedShares  Ownership
Nile Therapeutics, Inc.
Officer
NasdaqCM:NLTX
(historical quotes, profile, other insiders) 		7-Jul-09
11-Mar-09		14,152
   10,200
24,352		  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
7-Jul-09 3,952NLTX Purchase
13-Mar-09 5,000NLTX Purchase at $0.75 per share.
(Cost of $3,750)
11-Mar-09 *6,000NLTX Purchase at $0.77 per share.
(Cost of $4,620)
12-Dec-08 *3,186NLTX Purchase at $0.70 per share.
(Cost of $2,230)
12-Dec-08 1,000NLTX Purchase at $1.25 per share.
(Cost of $1,250)
11-Dec-08 *814NLTX Purchase at $0.54 per share.
(Cost of $439)
11-Dec-08 3,000NLTX Purchase at $0.81 per share.
(Cost of $2,430)
14-Apr-08 *600NLTX Purchase at $4.50 - $4.7 per share.
(Cost of about $2,760)
14-Apr-08 200NLTX Purchase at $4.50 per share.
(Cost of $900)

 

    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?